2.10
price down icon0.94%   -0.02
after-market アフターアワーズ: 2.15 0.05 +2.38%
loading
前日終値:
$2.12
開ける:
$2.1
24時間の取引高:
411.01K
Relative Volume:
0.30
時価総額:
$290.39M
収益:
-
当期純損益:
$-45.44M
株価収益率:
-6.00
EPS:
-0.35
ネットキャッシュフロー:
$-42.28M
1週間 パフォーマンス:
+0.48%
1か月 パフォーマンス:
+14.13%
6か月 パフォーマンス:
+28.83%
1年 パフォーマンス:
+54.41%
1日の値動き範囲:
Value
$2.06
$2.165
1週間の範囲:
Value
$2.06
$2.2299
52週間の値動き範囲:
Value
$0.765
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
名前
Compass Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
617-500-8099
Name
住所
80 GUEST STREET, BOSTON
Name
職員
35
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CMPX's Discussions on Twitter

CMPX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CMPX
Compass Therapeutics Inc
2.10 289.01M 0 -45.44M -42.28M -0.35
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 アップグレード Leerink Partners Market Perform → Outperform
2025-02-24 開始されました Guggenheim Buy
2025-02-19 開始されました Piper Sandler Overweight
2024-12-23 開始されました D. Boral Capital Buy
2024-11-15 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-16 アップグレード Ladenburg Thalmann Neutral → Buy
2023-01-31 開始されました Jefferies Buy
2023-01-27 開始されました Stifel Buy
2022-05-23 再開されました H.C. Wainwright Buy
2022-03-15 開始されました Ladenburg Thalmann Buy
2022-01-19 開始されました B. Riley Securities Buy
2021-12-22 開始されました Raymond James Outperform
2021-12-20 開始されました SVB Leerink Outperform
2021-12-15 開始されました Wedbush Outperform
すべてを表示

Compass Therapeutics Inc (CMPX) 最新ニュース

pulisher
May 29, 2025

Northern Trust Corp Sells 43,164 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Insider Buying: Thomas Schuetz Acquires Additional Shares of Com - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO Acquires 10,000 Shares - TradingView

May 27, 2025
pulisher
May 22, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 19, 2025

Dimensional Fund Advisors LP Buys New Stake in Babcock & Wilcox Enterprises, Inc. (NYSE:BW) - Defense World

May 19, 2025
pulisher
May 19, 2025

Bell Investment Advisors Inc Buys 79 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Dark Forest Capital Management LP Cuts Stock Holdings in NVIDIA Co. (NASDAQ:NVDA) - Defense World

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 19, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Bought by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Ceera Investments LLC Grows Stock Position in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Apple Inc. (NASDAQ:AAPL) is Sound View Wealth Advisors Group LLC’s Largest Position - Defense World

May 19, 2025
pulisher
May 19, 2025

Frontier Asset Management LLC Acquires 1,041 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Rebalance LLC Grows Stake in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Ocugen, Inc. (NASDAQ:OCGN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Sells 5,102 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 16, 2025
pulisher
May 14, 2025

Spotlight On Three Promising Penny Stocks In May 2025 - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Acquires 13,038 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts Compass Therapeutics (NASDAQ:CMPX) Price Target to $10.00 - Defense World

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $279,000 Stock Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Mariner LLC Purchases New Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Guggenheim Adjusts Price Target for Compass Therapeutics (CMPX) - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics (CMPX) Price Target Lowered by Guggenheim | CMPX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Compass Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 06, 2025

Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Grows Stock Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 05, 2025
pulisher
May 05, 2025

Cholangiocarcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

May 05, 2025
pulisher
May 03, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.4% in April - Defense World

May 03, 2025
pulisher
May 02, 2025

Was Compass Therapeutics Inc (CMPX)’s session last reading good? - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

JPMorgan Chase & Co. Acquires 227,864 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 02, 2025
pulisher
Apr 29, 2025

Compass Therapeutics Inc’s Market Journey: Closing Weak at 1.90, Down -2.06 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Compass Therapeutics (NASDAQ:CMPX) Given Buy Rating at D. Boral Capital - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Compass Therapeutics (CMPX) Unveils Promising Data at AACR Annua - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Cardiol Therapeutics announces annual shareholder meeting By Investing.com - Investing.com UK

Apr 28, 2025
pulisher
Apr 28, 2025

Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Position Increased by Geode Capital Management LLC - Defense World

Apr 28, 2025
pulisher
Apr 27, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 27, 2025
pulisher
Apr 27, 2025

2 Penny stocks to buy in May 2025 - Finbold

Apr 27, 2025
pulisher
Apr 24, 2025

It is Poised to be a Bull Market for Compass Therapeutics Inc (CMPX) - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Compass Therapeutics (NASDAQ:CMPX) Earns Buy Rating from Guggenheim - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

What was Compass Therapeutics Inc (CMPX)’s performance in the last session? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Compass Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.2378: Will the Stock Break Through? - investchronicle.com

Apr 23, 2025
pulisher
Apr 22, 2025

Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from HC Wainwright - Defense World

Apr 22, 2025
pulisher
Apr 22, 2025

Compass Therapeutics (NASDAQ:CMPX) Given “Buy” Rating at D. Boral Capital - Defense World

Apr 22, 2025

Compass Therapeutics Inc (CMPX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):